2017 / 04

Next Paper
DOI: 10.24075/brsmu.2017-04-02

METHOD

The use of wild-type blocking allele-specific real-time polymerase chain reaction for the analysis of somatic mutations in RAS genes of circulating free DNA isolated from the blood plasma of patients with colorectal cancer

Telysheva EN, Snigireva GP
About authors

Laboratory of Molecular Biology and Cytogenetics,
Russian Research Center of Roentgenoradiology, Moscow, Russia

Correspondence should be addressed: Galina Snigireva
ul. Profsoyuznaya, d. 86, Moscow, Russia, 117997; ur.liam@lag_ins

About paper

Acknowledgements: the authors thank Andrey Zaretsky of Evrogen (Moscow) for his help and valuable advice in conducting molecular genetic analysis.

Contribution of the authors to this work: Telysheva EN — analysis of literature, research planning, data collection, analysis, and interpretation, drafting of a manuscript; Snigireva GP — research planning, data interpretation, drafting of a manuscript.

Received: 2017-08-08 Accepted: 2017-08-17 Published online: 2017-10-29
|
  1. Zborovskaya IB. [Modern strategies for study of tumor’s markers in clinical practic]. Advances in molecular oncology. 2014; 2: 4–15. DOI: 10&17650/2313-805X.2014.1.2.4-15. Russian.
  2. Manne U, Jadhav T, Putcha BK. Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective. Curr Colorectal Cancer Rep. 2016; 12 (6): 332–44. DOI: 10.1007/s11888-016-0338-1.
  3. Overman MJ, Modak J, Kopetz S, Murthy R, Yao JC, Hicks ME et al. Use of research biopsies in clinical trials: Are risks and benefits adequately discussed? J Clin Oncol. 2013 Jan 1; 31 (1): 17–22. DOI: 10.1200/JCO.2012.43.1618.
  4. Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012 Mar 8; 366 (10): 883–92. DOI: 10.1056/NEJMoa1113205. Erratum in N Engl J Med. 2012 Sep 6; 367 (10): 976.
  5. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer – A survey. Biochim Biophys Acta. 2007 Jan; 1775 (1): 181–232. DOI: 10.1016/j.bbcan.2006.10.001.
  6. Gonzalez JA, Garcia-Olmo D, Garcia-Olmo DC. Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. OncoTargets Ther. 2013 Jul 8; 6: 819–32. DOI: 10.2147/OTT.S44668.
  7. Ma M, Zhu H, Zhang C, Sun X, Gao X, Chen G. “Liquid biopsy” – ctDNA detection with great potential and challenges. Ann Transl Med. 2015 Sep; 3 (16): 235. DOI: 10.3978/j.issn.2305-5839.2015.09.29.
  8. Diaz LA Jr, Bardelli A. Liquid Biopsies: Genotyping Circulating Tumor DNA. J Clin Oncol. 2014 Feb 20; 32 (6): 579–86. DOI: 10.1200/JCO.2012.45.2011.
  9. Beije N, Helmijr JC, Weerts MJA, Beaufort CM, Wiggin M, Marziali A et al. Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases. Mol Oncol. 2016 Dec; 10 (10): 1575–84. DOI: 10.1016/j.molonc.2016.10.001.
  10. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008 Sep; 14 (9): 985–90. DOI: 10.1038/nm.1789.
  11. Holdhoff M, Schmidt K, Donehower R, Diaz LA. Analysis of circulating tumor DNA to confirm somatic KRAS mutations. J Natl Canc Inst. 2009; 101 (18): 1284-–5. DOI: 10.1093/jnci/djp240.
  12. Chen KZ, Lou F, Yang F, Zhang JB, Ye H, Chen W et al. Circulating tumor DNA detection in early-stage non-small cell-lung cancer patients by targeted sequencing. Sci Rep. 2016 Aug 24; 6: 31985. DOI: 10.1038/srep31985.
  13. Rachiglio AM, Abate RE, Sacco A, Pasquale R, Fenizia F, Lambiase M et al. Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma. Oncotarget. 2016 Oct 11; 7 (41): 66595–605. DOI: 10.18632/oncotarget.10704.
  14. Tu M, Chia D, Wei F, Wong D. Liquid biopsy for etection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB). Analyst. 2016 Jan 4; 141 (2): 393–402. DOI: 10.1039/c5an01863c.
  15. Belousova AV, Drozd OV, Zaretskiy AR. Mutatsionno-spetsificheskaya polimeraznaya tsepnaya reaktsiya dlya analiza mutatsiy v «goryachikh tochkakh» genov K-Ras i B-Raf v biologicheskikh obraztsakh onkologicheskikh bol'nykh. In: Tezisy konferentsii «Sovremennye printsipy diagnostiki i lecheniya kolorektal'nogo raka», posvyashchennoy pamyati prof. V. I. Knysha; 2011 May 26–27; Moscow, Russia. Moscow: 2011. p. 16.
  16. Telysheva EN. [Identification of molecular-genetic oncomarkers with using invasive and non-invasive methods of investigation]. Oncology Bulletin of the Volga Region. 2014; 3: 60–4. Russian.
  17. Kim K, Shin DG, Park MK, Baik SH, Kim TH, Kim S et al. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection. Ann Surg Treat Res. 2014 Mar; 86 (3): 136–42. DOI: 10.4174/astr.2014.86.3.136.
  18. Qin Z, Ljubimov VA, Zhou C, Tong Y, Liang J. Cell‑free circulating tumor DNA in cancer. Chin J Cancer. 2016 Apr 7; 35: 36. DOI: 10.1186/s40880-016-0092-4.
  19. Zakharenko AA, Zaytsev DA, Belyaev MA, Trushin AA, Ten OA, Natkha AS. Vozmozhnosti zhidkoy biopsii pri rake zheludka. Problems in Oncology. 2016; 62 (4): 379–85. Russian.
  20. Tamkovich SN, Vlassov VV, Laktionov PP. Circulating DNA in in the blood and its application in medical diagnosis. Molecular Biology. 2008; 42 (1): 9–19.
  21. Vasilyeva IN, Bespakov VG. [Role of extracellular DNA in the appearance and development of malignant tumors and possibilities of its use in the diagnosis and treatment of cancer]. Problems in Oncology. 2013; 59 (6): 673–81. Russian.
  22. Nemtsova MV, Paltseva EM, Babayan AYu, Mihaylenko DS, Babenko OV, Zaletaev DV et al. Molecular genetic analysis of the intratumoral clonal heterogeneity of colorectal adenocarcinomas. Molecular Biology. 2008; 42 (6): 925–31.